Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flow from operating activities:
Net loss	$ (36,489)	$ (14,740)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense	3,747	1,189
Depreciation and amortization expense	48	7
Accretion of discounts and amortization of premiums on investments, net	(324)
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	4,375	(2,121)
Other long-term assets	(407)	(278)
Accounts payable	3,117	1,654
Accrued and other liabilities	1,635	(33)
Operating lease assets and liabilities, net	41	16
Net cash used in operating activities	(24,257)	(14,306)
Cash flow from investing activities:
Purchases of short-term investments	(97,363)
Sales and maturities of short-term investments	89,994
Purchases of property and equipment	(191)	(96)
Net cash used in investing activities	(7,560)	(96)
Cash flow from financing activities:
Proceeds from sale of Series A redeemable convertible preferred stock, net of issuance costs		63,512
Payments for deferred offering costs	(135)
Proceeds from exercise of stock options	174
Proceeds from issuance of common stock, net of issuance costs		127,195
Net cash provided by financing activities	39	190,707
Net (decrease) increase in cash and cash equivalents	(31,778)	176,305
Cash and cash equivalents at the beginning of the year	54,197	4,573
Cash and cash equivalents at the end of the period	22,419	180,878
Supplemental disclosure of noncash investing and financing activities:
Right-of-use asset obtained in exchange for operating lease liability	765	583
Deferred offering costs included in accounts payable	149	250
Purchases of property and equipment in accounts payable		$ 34